| Anemia como factor pronóstico en pacientes con cáncer V Paitan, C Alcarraz, A Leonardo, G Valencia, R Mantilla, Z Morante, ... Revista Peruana de Medicina Experimental y Salud Publica 35, 250-258, 2018 | 34 | 2018 |
| Immunotherapy in triple-negative breast cancer: A literature review and new advances GA Valencia, P Rioja, Z Morante, R Ruiz, H Fuentes, CA Castaneda, ... World Journal of Clinical Oncology 13 (3), 219, 2022 | 22 | 2022 |
| Anemia as a prognostic factor in cancer patients V Paitan, C Alcarraz, A Leonardo, G Valencia, R Mantilla, Z Morante, ... Revista Peruana de Medicina Experimental y Salud Publica 35 (2), 250-258, 2018 | 15 | 2018 |
| Breast cancer subtype and clinical characteristics in women from Peru VA Zavala, S Casavilca-Zambrano, J Navarro-Vasquez, LI Tamayo, ... Frontiers in Oncology 13, 938042, 2023 | 5 | 2023 |
| Adaptation of international coronavirus disease 2019 and breast cancer guidelines to local context GA Valencia, S Neciosup, HL Gómez, MDP Benites, S Falcón, D Moron, ... World journal of clinical oncology 12 (1), 31, 2021 | 5 | 2021 |
| Association between ancestry-specific 6q25 variants and breast cancer subtypes in Peruvian women VA Zavala, S Casavilca-Zambrano, J Navarro-Vásquez, CA Castañeda, ... Cancer Epidemiology, Biomarkers & Prevention 31 (8), 1602-1609, 2022 | 3 | 2022 |
| Renal liposarcoma: case report and review of systemic treatment P Rioja, G Valencia, C Centurión-Rodriguez, Z Morante, M Bravo, ... ecancermedicalscience 15, 2021 | 3 | 2021 |
| PIK3CA mutation in non-metastatic triple-negative breast cancer as a potential biomarker of early relapse: A case report GA Valencia, P Rioja, Z Morante, JM Araujo, HD Vallejos, H Guerra, ... World Journal of Clinical Oncology 12 (8), 702, 2021 | 2 | 2021 |
| COVID-19 pandemic impact on the oncology care using a virtual survey in Peru. G Valencia, D Enriquez, P Rioja, L Lachira, M Calderon, ... Journal of Clinical Oncology 41 (16_suppl), e18738-e18738, 2023 | 1 | 2023 |
| The current situation regarding the availability and accessibility of anticancer drugs for breast cancer in the Peruvian public health systems G Valencia-Mesías, P Rioja-Viera, Z Morante-Cruz, Y Toledo-Morote, ... ecancermedicalscience 15, 2021 | 1 | 2021 |
| Abstract PO1-28-03: Impact of the Oncotype DX® test over time and association with clinicopathological characteristics of Peruvian patients with early breast cancer: Experience … SKG Bocanegra, G Mesías, YAF Chombo, KTM Garcia, M Lopez-Pereyra, ... Cancer Research 84 (9_Supplement), PO1-28-03-PO1-28-03, 2024 | | 2024 |
| Treatment sequencing and overall survival of HER2-positive advanced breast cancer in a Peruvian institution. HLG Guillermo Valencia, Patricia Rioja, Olenka Peralta, Miguel Chirito ... The Breast 71, 2023 | | 2023 |
| Quality of life during medical oncological treatment in a real-world study in a single-institution of Peru. P Rioja, G Valencia, JM Araujo, JA Pinto, A Godenzi, B Neciosup, ... Journal of Clinical Oncology 41 (16_suppl), e18735-e18735, 2023 | | 2023 |
| Testicular GERM cell tumors treatment outcome in a national cancer institution in Peru. P Rioja, G Valencia, Z Morante, H Fuentes, R Mantilla, ... Journal of Clinical Oncology 41 (16_suppl), e17031-e17031, 2023 | | 2023 |
| Real-world efficacy of nivolumab in Peruvian patients with advanced melanoma. K Roque, G Valencia, P Rioja, A huaman Campos, V Colomo Costas, ... Journal of Clinical Oncology 41 (16_suppl), e18849-e18849, 2023 | | 2023 |
| Regulation of genes located in 6q25 by an Indigenous American genetic variant in breast cancer patients from Peru VA Zavala, X Huang, S Casavilca-Zambrano, J Navarro-Vásquez, ... Cancer Research 83 (7_Supplement), 5237-5237, 2023 | | 2023 |
| Zaida Morante1, 2, Yomali Ferreyra3, Joseph A. Pinto4, Natalia Valdivieso1, Carlos Castañeda1, Tatiana Vidaurre1, Guillermo Valencia1, Patricia Rioja1, Hugo Fuentes1, Jose M … N Valdivieso, C Castañeda, T Vidaurre, G Valencia, P Rioja, H Fuentes, ... | | 2023 |
| Subpopulation treatment effect pattern plot analysis: a prognostic model for distant recurrence-free survival to estimate delayed adjuvant chemotherapy initiation effect in … Z Morante, Y Ferreyra, JA Pinto, N Valdivieso, C Castañeda, T Vidaurre, ... Frontiers in Oncology 13, 2023 | | 2023 |
| Abstract C082: Breast cancer risk in Hispanic/Latina women and the 6q25 chromosomal region: Fine mapping and eQTL identification VA Zavala, X Huang, S Casavilca-Zambrano, J Navarro-Vásquez, ... Cancer Epidemiology, Biomarkers & Prevention 32 (1_Supplement), C082-C082, 2023 | | 2023 |
| Latest advances in neoadjuvant therapy for bladder cancer. P Rioja, G Valencia, Z Morante, R Paz, H Vallejos, H Fuentes, S Neciosup | | 2022 |
